Study of Postprandial Incretin Response in Women With Gestational Diabetes
NCT ID: NCT01274052
Last Updated: 2011-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
19 participants
OBSERVATIONAL
2007-03-31
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The researchers aimed to investigate whether women with gestational diabetes mellitus exhibit decreased postprandial GLP-1 responses, and if so, whether this deficiency ceases following delivery when normal glucose tolerance is reestablished.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glucagon Responses During Oral- and iv Glucose in Patients With Type 1 Diabetes
NCT00704795
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827
The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
NCT00732602
GIP Receptor Antagonist Studies in Humans
NCT02747472
Effect of GIP After a Meal in Patients With Type 2 Diabetes
NCT03702660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The researchers aimed to investigate whether women with gestational diabetes mellitus exhibit decreased postprandial GLP-1 responses, and if so, whether this deficiency ceases following delivery when normal glucose tolerance is reestablished.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gestational Diabetes Mellitus
Women with Gestational Diabetes Mellitus
Meal test
Liquid meal test
Normal Glucose Tolerance
Women with Normal Glucose Tolerance
Meal test
Liquid meal test
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meal test
Liquid meal test
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to participate
Exclusion Criteria
* Diabetes before pregnancy
* Positive islet cell- and GAD-65 autoantibodies
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Danish Diabetes Association
OTHER
Aase and Ejnar Danielsens Foundation
OTHER
The Novo Nordic Foundation
OTHER
University Hospital, Gentofte, Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Internal Medicine F, University Hospital, Gentofte, Copenhagen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Filip K Knop, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Diabetes Research Division, Gentofte Hopsital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Internal Medicine, Glostrup Hospital
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hare KJ, Bonde L, Svare JA, Randeva HS, Asmar M, Larsen S, Vilsboll T, Knop FK. Decreased plasma chemerin levels in women with gestational diabetes mellitus. Diabet Med. 2014 Aug;31(8):936-40. doi: 10.1111/dme.12436. Epub 2014 Apr 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KA-060015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.